International Hellenic University
Μελέτη ενζύμων του μεταβολισμού των υδατανθράκων που σχετίζονται με την παθοφυσιολογία του διαβήτη με έμφαση στην DPP-4 και PTP1b και της δυνατότητας εύρεσης ειδικών αναστολέων με πιθανή εφαρμογή στη θεραπεία και τη διαγνωστική
Abstract
dc:descriptionType 2 Diabetes Mellitus (T2DM) is a multifactorial metabolic disease characterized mainly by chronic hyperglycemia and insulin resistance, accounting for approximately 90–95% of diabetes cases. The present doctoral dissertation focuses on the discovery of novel inhibitors of the enzymes DPP4 and PTP1b. Inhibition of DPP4 enhances glucose-dependent insulin secretion and improves β-cell function, while inhibition of PTP1b contributes to the reduction of insulin resistance. The aim of this thesis was the identification of novel DPP4 and PTP1b inhibitors with emphasis on allosteric inhibitors, the discovery of dual-acting inhibitors, as well as the investigation of DPP4 isoform variations in serum from patients with T2DM, other DPP4-related pathological conditions(cancer, Alzheimer’s disease), and healthy individuals. For this purpose, sixteen synthetic derivatives of 3-(benzo[d]thiazol-2-yl)-2-arylthiazolidin-4-one and nineteen plant-derived compounds were studied, of which eight were isolated from Thymus thracicus Velen and eleven from Centaurea bruguieriana subsp. belangeriana. For the separation of the isoforms, Western blot/immunoblot and chromatographic techniques were applied. Initially, computational docking analysis were performed to predict inhibitory activity, followed by in vitro enzyme assays. The type of inhibition was investigated through kinetic studies, with extensive analysis for DPP4 and determination of Km and Vmax values using Lineweaver–Burk plots. Based on these results, an improved predictive model was developed by introducing a Probability Factor(PF) to estimate IC50 values and facilitate compound selection for further studies. Regarding DPP4, the results demonstrated that twelve of the sixteen synthetic derivatives strongly inhibited the enzyme, with IC50 values in the nM range, while five exhibited higher potency than approved inhibitors. In addition, four compounds exhibited a type of inhibition other than competitive (allosteric or mixed). Among the plant-derived compounds from Thymus thracicus, seven inhibited DPP4, with four displaying non-competitive or mixed inhibition, whereas two compounds from Centaurea bruguieriana showed uncompetitive inhibition with IC50 values in the μM range. Concerning PTP1b, seven synthetic and ten plant-derived compounds showed notable inhibitory action with IC50 values in the μM range. Furthermore, six synthetic and seven plant-derived compounds exhibited a type of inhibition other than competitive (allosteric or mixed). Seven synthetic and eight plant-derived dual-acting inhibitors against both DPP4 and PTP1b were identified, with one synthetic and six plant-derived compounds, exhibiting allosteric or mixed inhibition toward both enzymes. Using electrophoresis, electrotransfer, and immunodetection techniques (Western blot/Immunoblot), as well as chromatographic methods, distinct DPP4 isoforms were identified in T2DM patients’ serum compared to other pathological conditions and healthy individuals. The observed differences concerned both molecular weight and isoelectric point. Following partial purification of the isoforms and testing with synthetic inhibitors, it was demonstrated that the studied competitive inhibitors acted competitively with isoform-dependent potency, whereas inhibitors exhibiting allosteric or mixed inhibition displayed different inhibition modes and potencies depending on the specific DPP4 isoform.
Degree
thesis:*- Grantor dc:publisher
- International Hellenic University
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Amanatidou, Dionysia
- Αμανατίδου, Διονυσία
Subjects
dc:subject × 119- Διαβήτης
- Σακχαρώδης διαβήτης
- Σακχαρώδης διαβήτης τύπου 2
- Σακχαρώδης διαβήτης τύπου ΙΙ
- ΣΔ2
- Αντιδιαβητικά φάρμακα
- Διπεπτίδυλο πεπτιδάση 4
- Ισομορφές DPP4
- Αναστολείς DPP4
- Φωσφατάση πρωτεϊνών τυροσύνης 1b
- Αναστολείς PTP1b
- Αλλοστερικό κέντρο
- Αναστολείς ενζύμων
- Συναγωνιστικοί αναστολείς
- Μη-συναγωνιστικοί αναστολείς
- Ανταγωνιστικοί αναστολείς
- Μεικτοί αναστολείς
- Μελέτη κινητικής
- Διαγράμματα διπλού αντιστρόφου
- Βιοπληροφορική
- Πρόβλεψη αναστολής
- Παράγοντας πιθανότητας
- Ηλεκτροφόρηση
- Ανοσοανίχνευση
- Χρωματογραφία ιόντων
- Χρωματογραφία
- Κυτταροκαλλιέργια
- Κυτταροτοξικότητα
- Πρόβλεψη τοξικότητας
- 3-(βενζο[d]θειαζολ-2-υλ)-2-αρυλοθειαζολιδιν-4-όνης
- Παράγωγα θειαζολιδιν-4-όνης
- Φυσικά προϊόντα
- Φαρμακευτικά φυτά
- Αδενοκαρκίνωμα του πνεύμονα
- Νόσος Αλτσχάιμερ (ΝΑ)
- Καρκίνος
- 8α-Ο-(3’, 4’-διυδροξυ-2’-μεθυλενο-βουτανοϋλοξυ)-δεϋδρομελιτενσίνη
- Κνικίνη
- Μαλασιτανολίδιο
- 3-O-β-D-γλυκοπυρανοσίδης της 6-μεθοξυκαιμπφερόλης
- Αστραγαλίνη
- p-OH βενζοϊκό οξύ
- 3-υδροξυ-2-μεθυλο-βουτυρολακτόνη
- Καφεϊκός μεθυλεστέρας
- Ροσμαρινικός μεθυλεστέρας
- Ροσμαρινικό οξύ
- Λιθοσπερμικός διμεθυλεστέρας
- 9″- λιθοσπερμικός μεθυλεστέρας
- 2-(3,4-διυδροξυφαινυλ)αιθυλ-γλυκοπυρανοσίδη
- Diabetes
- Diabetes mellitus
- Diabetes mellitus type II
- Diabetes mellitus type 2
- Anti-diabetic drugs
- Dipeptidyl peptidase 4
- DPP4 inhibitors
- DPP4
- Protein tyrosine phosphatase 1b
- PTP1b inhibitors
- Allosteric inhibitor
- Enzyme inhibitors
- Competitive
- Non competitive
- Uncompetitive
- Mixed
- Enzyme kinetics
- Lineweaver-burk plots
- IC50
- Km
- Vmax
- Km and Vmax
- Bioinformatics
- Docking Analysis
- Probability Factor
- PF
- Electrophoresis
- Native
- SDS
- Immunoblot
- Western blot
- Chromatography
- Ion Exchange Chromatography
- Cytotoxicity
- Caco2
- MTT assay
- 3-(benzo[d]thiazol-2-yl)-2-aryl thiazolidin-4-ones derivatives
- Thymus thracicus Velen
- Centaurea bruguieriana subsp. Belangeriana
- Centaurea bruguieriana
- Lung adenocarcinoma
- Alzheimer's disease
- Cancer
- 8-alpha-O-(3′,4′-dihydroxy-2′-methylene-butanoyloxy)-dehydromelitensin
- Cnicin
- Malacitanolide
- 3-O-β-D-glucopyranoside of 6-methoxykaempferol
- Astragalin
- p-hydroxybenzoic acid
- 3-hydroxy-2-methyl-butyrolactone
- Methyl caffeate
- Methyl rosmarinate
- Rosmarinic acid
- Dimethyl lithospermate
- 9”-Methyl lithospermate
- Calceolarioside A
- 2(3,4-dihydroxy) phenylethyl-glucopyranoside
- DEAE
- Επιστήμη Ηλεκτρονικών Υπολογιστών και Πληροφορική
- Φυσικές Επιστήμες
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ιατρική βιοχημεία
- Ανακάλυψη και Ανάπτυξη φαρμάκων
- Computer and Information Sciences
- Natural Sciences
- Basic Medicine
- Medical and Health Sciences
- Medical Biochemistry
- Drug Discovery
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60523